Evidence map›Paper›PMID 38683494›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2024

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.

Rachel S Newson, Victoria Divino, Kristina S Boye, Justin Chen, Mitch DeKoven, Carlos Vallarino, Kari Ranta, Julie E Mount

Abstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Psychological Distress and Disordered Eating in Adults Attending an Obesity Outpatient Clinic.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel S NewsonEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.ORCID http://orcid.org/0000-0002-2653-5797
Victoria DivinoIQVIA, 3110 Fairview Park Drive, Suite 400, Falls Church, VA, 22042, USA. victoria.divino@iqvia.com.ORCID http://orcid.org/0000-0001-5555-7912
Kristina S BoyeEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.ORCID http://orcid.org/0000-0002-5953-5929
Justin ChenIQVIA, 3110 Fairview Park Drive, Suite 400, Falls Church, VA, 22042, USA.ORCID http://orcid.org/0009-0002-7960-9697
Mitch DeKovenIQVIA, 3110 Fairview Park Drive, Suite 400, Falls Church, VA, 22042, USA.ORCID http://orcid.org/0000-0001-9346-6202
Carlos VallarinoEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.ORCID http://orcid.org/0000-0002-0929-2260
Kari RantaEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.ORCID http://orcid.org/0009-0006-4126-3714
Julie E MountEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.ORCID http://orcid.org/0000-0003-2185-151X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn people with type 2 diabetes (PwT2D) who also have obesity, efforts targeting weight loss, including lifestyle, medication and surgical interventions, are recommended. The objective of this study was to explore the relationship between glycemic control and obesity among PwT2D in Europe and Australia using recent real-world data and applying consistent methodology across countries.

methodsRetrospective study utilizing IQVIA electronic medical records (EMR) databases grouped into panels based on specialty of contributing physicians. General practitioner (GP) and endocrinologist/diabetologist (E/D) panels were used in Germany and France, while GP panels were used in Italy, UK and Australia. The Spanish database included all physician specialties. The sample included PwT2D with glycated hemoglobin A1c (HbA1c) and body mass index (BMI) values measured within 90 days of each other between January 2015 and December 2018 (second record termed the 'index date'). PwT2D had a 1-year baseline period and a recorded HbA1c at the end of the 1-year post-index period.

resultsThe final sample comprised 194,729 PwT2D. At baseline, across countries/panels, 36.8-58.0% were above HbA1c target (HbA1c ≥ 7%) and 39.4-56.7% had obesity (BMI ≥ 30.0 kg/m

conclusionsThis study presents data on HbA1c and BMI among type 2 diabetes (T2D) populations in Europe and Australia. A notable proportion of PwT2D had obesity and were above HBA1c target. Higher BMI was associated with poorer glycemic control.

Indexed as

Cohort studyDatabase researchGlycemic controlObservational studyType 2 diabetes

Identifiers

PMID38683494
PMCPMC11096291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.